A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia
Clinical trial NCT03465787 · COMPLETED
Trial details
- NCT number
- NCT03465787
- Sponsor
- Bukwang Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-09
- Primary completion
- 2022-10-26
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.